Diagnostic value of plasma vascular endothelial growth factor as a tumor marker in patients with non-small cell lung cancer

International Journal of Biological Markers

Volumn 17, Issue 4, 2002, Pages 275-279

  Tamura, Masaya ^a   Ohta, Y ^b   Nakamura, H ^a   Oda, M ^a   Watanabe, G ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b ISHIKAWA PREFECTURAL CENTRAL HOSPITAL   (Japan)

Author keywords

Carcinoembryonic antigen (CEA); Cytokeratin 19 (CYFRA); Enzyme linked immunosorbent assay (ELISA); Lung cancer; Plasma vascular endothelial growth factor

Indexed keywords

BIOLOGICAL MARKER; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 19; VASCULOTROPIN;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER STAGING; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISCRIMINANT ANALYSIS; DISEASE MARKER; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNORADIOMETRIC ASSAY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; VOLUNTEER;

EID: 12244310210     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.5301/JBM.2008.620     Document Type: Article

References (18)

1. Kondo S, Asano M, Matsuo K, Ohmori I, Suzuki H. Vascular endothelial growth factor/vascular permeability factor is detectable in sera of tumor-bearing mice and cancer patients. Biochim Biophys Acta 1994; 1221: 211-4.
2. Yamamoto Y, Toi M, Kondo S, Matsumoto T, Suzuki H, Kitamura M. Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients. Clin Cancer Res 1996; 2: 821-6.
3. Obermair A, Tempfer C, Hefler L, Preyer O, Kaider A, Zeilliner R. Concentration of vascular endothelial growth factor (VEGF) in the serum of patients with suspected ovarian cancer. Br J Cancer 1998; 77: 1870-4.
4. Homer JJ, Anyanwu K, Ell SR, Greenmach J, Stafford ND. Serum vascular endothelial growth factor in patients with head and neck squamous cell carcinoma. Clin Otolaryngol 1999; 24: 426-30.
5. Yoshikawa T, Tsuburaya A, Kobayashi O, Sairenji M, Motohashi H, Yanoma S. Plasma concentrations of VEGF and bFGF in patients with gastric carcinoma. Cancer Lett 2000; 153: 7-12.
6. Harish K, Kamal H, Peter WRL, Graeme SD, Alastair WM, John G. Preoperative serum vascular endothelial growth factor can predict stage in colorectal cancer. Clin Cancer Res 1998; 4:1279-85.
7. Oehler MK Caffier H. Diagnostic value of serum VEGF in women with ovarian tumors. Anticancer Res 1999; 19: 2519-22.
8. Tamura M, Ohta Y, Kajita T, Kimura K, Go T, Oda M. Plasma VEGF concentration can predict the tumor angiogenic capacity in non-small cell lung cancer. Oncol Rep 2001; 8: 1097-102.
9. Maeda K, Chung Y-S, Ogawa Y. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer 1996; 77: 858-63.
10. Balsari A, Maier JA, Colnaghi MI, Menard S. Correlation between tumor vascularity, vascular endothelial growth factor production by tumor cells, serum vascular endothelial growth factor levels, and serum angiogenic activity in patients with breast carcinoma. Lab Invest 1999; 79: 897-902.
11. Ohta Y, Endo Y, Tanaka M, Shimizu J, Oda M, Hayashi Y. Significance of vascular endothelial growth factor messenger RNA expression in primary lung cancer. Clin Cancer Res 1996; 2: 1411-6.
12. Yamamoto S, Konishi I, Mandai M, et al. Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: Correlation with clinicopathology and patient survival, and analysis of serum VEGF levels. Br J Cancer 1997; 76: 1221-7.
13. Takeda A, Shimada H, Imaseki H, Okazumi S, Natsume T, Ochiai T. Clinical significance of serum vascular endothelial growth factor in colorectal cancer patients: Correlation with clinicopathological factors and tumor markers. Oncol Rep 2000; 7: 333-8.
14. Vermeulen PB, Salven P, Benoy I, Gasparini G, Dirix LY. Blood platelets and serum VEGF in cancer patients. Br J Cancer 1999; 79: 370-6.
15. Wynendaele W, Derua R, Hoylaerts MF, Oawinski A, Waelkens E, Bruijn EA. Vascular endothelial growth factor measured in platelet poor plasma allows optimal separation between cancer patients and volunteers: A key to study an angiogenic marker in vivo. Ann Oncol 1999; 10: 965-71.
16. Dittadi R, Meo S, Fabris F, Gasparini G, Contri D, Medici M. Validation of blood collection procedures for the determination of circulating vascular endothelial growth factor (VEGF) in different blood compartments. Int J Biol Markers 2002; 17: 119-24.
17. Slentz K, Senagore A, Hibbert J. Can preoperative and postoperative CEA predict survival after colon cancer resection? Am Surg 1994; 60: 528-32.
18. Yeal HK, Jaffer AA, David MO. Value of carcinoembryonic antigen levels in patients with resectable adenocarcinoma of esophagus and stomach. Cancer 1995; 75: 451-6.